Loss of CXCR3 expression on memory B cells in individuals with long-standing type 1 diabetes

Overview of attention for article published in Diabetologia, June 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 34 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Elevated glucose metabolism driving pro-inflammatory response in B cells contributes to the progression of type 1 diabetes

Article in Clinical Immunology (August 2023)

Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes

Article in Clinical & Experimental Immunology (July 2023)

Identification of an anergic BND cell–derived activated B cell population (BND2) in young-onset type 1 diabetes patients

Article in Journal of Experimental Medicine (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.